Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Banaja Holdings
Banaja Holdings
Activities:
Distribution
Trending Articles
Lonza appoints Andreas Bohrer as Chief Legal & Corporate Affairs Officer
As of 1 July 2025, Andreas joins Lonza’s Executive Committee as Chief Legal & Corporate Affairs Officer
eXmoor Pharma teams up with KU Leuven to advance AAV innovation
The CDMO and academic institute will co-develop adeno-associated virus (AAV) cell lines and manufacturing processes
Inventprise selects Quantoom’s production technology to advance mRNA vaccine development
Inventprise has announced its selection of Quantoom Biosciences’ Ntensify midi system as the core technology to support its mRNA vaccine platform
You need to be a subscriber to read this article.
Click here
to find out more.
Bioprinting in cancer treatment: improving models, accelerating drug development and overcoming research challenges
As global cancer diagnoses increase — projected to reach 35 million new cases annually by 2040 — the need for more effective and economically sustainable oncology therapies...
Causes and solutions for dark spots in tablet manufacturing
Natoli Engineering examines the causes and solutions for dark spots that can halt production
Upcoming event
Cleanroom Technology Conference UK
21–22 May 2025 | Conference and Exhibition | Birmingham, UK
See all
Related Content
Finance
Tranzone secures GSK deal
Will store various products in Jebel Ali for distribution to the Gulf and Near East Region
Manufacturing
Banaja takes majority stake in DEEF Pharmaceutical
Aims to expand and diversify DEEF facility in Saudi Arabia
Subscribe now